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Background: MicroRNAs (miRNA) are small endogenously transcribed regulatory RNA which modulates gene
expression at a post transcriptional level. These small RNAs have now been shown to be critical regulators in a
number of biological processes in the cell including pathophysiology of diseases like cancers. The increasingly
evident roles of microRNA in disease processes have also motivated attempts to target them therapeutically.
Recently there has been immense interest in understanding small molecule mediated regulation of RNA, including
microRNA.
Results: We have used publicly available datasets of high throughput screens on small molecules with potential to
inhibit microRNA. We employed computational methods based on chemical descriptors and machine learning to
create predictive computational models for biological activity of small molecules. We further used a substructure
based approach to understand common substructures potentially contributing to the activity.
Conclusion: We generated computational models based on Naïve Bayes and Random Forest towards mining small
RNA binding molecules from large molecular datasets. We complement this with substructure based approach to
identify and understand potentially enriched substructures in the active dataset. We use this approach to identify
miRNA binding potential of a set of approved drugs, suggesting a probable novel mechanism of off-target activity
of these drugs. To the best of our knowledge, this is the first and most comprehensive computational analysis
towards understanding RNA binding activities of small molecules and predictive modeling of these activities.
Keywords: microRNA, Machine learning, Maximum common substructure (MCS)Background
MicroRNAs are a well characterized class of small non-
coding RNAs now known to be encoded in the genomes
of a wide variety of eukaryotes spanning the plant and ani-
mal kingdoms of life [1,2]. Recent advancements in the
availability of computational and experimental tools have
triggered increasing levels of interest to predict and ex-
perimentally validate microRNAs and their biological tar-
gets and understand their regulatory roles in a wide
variety of organisms [3-5]. MicroRNAs typically mediate
post-transcriptional regulation of protein-coding genes by
binding to the 3’ un-translated regions of the transcripts
[6,7]. A number of microRNAs are known to modulate* Correspondence: vinods@igib.res.in
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reproduction in any medium, provided the orregulation of crucial oncogenes and function both by pro-
moting as well as suppressing oncogenesis and form a dis-
tinct class popularly termed as ‘oncomiRs’ [8]. Due to
their ubiquitous role in pathological processes, it has been
suggested that microRNAs could act as potential drug tar-
gets [9-12].
RNA-binding molecules offer an attractive strategy for
modulating microRNAs function. The current literature
points to a large number of classes of small molecules, in-
cluding many therapeutically active classes of molecules
which have RNA-binding potential [13,14]. In addition a
large number of studies have shown potential small-
molecules which can bind and modulate non-coding RNA
functions [15,16]. Some of the reported molecules like
aurintricarboxylic acid, suramin and oxidopamine modu-
late microRNA processing by inhibiting microRNA load-
ing on the RNA Induced Silencing complex [16], while
molecules like enoxacin, a fluoroquinolone antibacteriall Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a cancer-specific manner [14].
Techniques and assays for screening of small molecules
with potential to modulate microRNA function and or ac-
tion [16] apart from phenotypic or specific expression
based screens have been increasingly being adapted for
high-throughput screening strategies. The recent advance-
ments in synthesis of compounds and large numbers of
new compound libraries currently available for biological
screening, poses a high demand for predictive computa-
tional methods that can prioritize molecules for biological
screening. Previous studies [17,18] have shown the appli-
cation of Machine Learning in predictive modeling of
molecules from high-throughput datasets available in pub-
lic domain. We have previously used similar strategies
using 2D descriptors and activities reported from high-
throughput screen data available in public databases like
PubChem for prioritization of small molecules with anti-
tubercular action based on modeling activities based on
concepts of machine learning [19,20]. Apart from Machine
learning chemical similarity searching by means of com-
mon substructures has been widely used for predicting po-
tential biological activities of compounds and identifying
frequently occurring molecular scaffolds in large molecu-
lar libraries [21,22].
Here in this manuscript, we describe a computational
strategy for predictive modeling of small molecules with
potential to inhibit specific microRNAs, based on ma-
chine learning from high-throughput screen dataset for
modulators of microRNA mir-21 [13], a well studied
oncomiR. We show that the methodology is highly ac-
curate with low false positivity. This methodology could
be potentially used for computational prioritization of
small molecules before performing high-throughput bio-
logical assay. We extend our study to analyze common
chemical substructures shared between biologically ac-
tive molecules using a Maximum Common Substructure
(MCS) approach. To the best of our knowledge this is
the first comprehensive analysis of predictive modeling
of small-molecule modulators of microRNA.
Results and discussion
Model construction using machine learning algorithms
The bioassay datasets downloaded from PubChem were
used to generate 179 2D molecular descriptors using
PowerMV. Data processing (described in Materials
and Methods) resulted in 154 molecular descriptors
(Additional file 1). The training file was loaded in WekaTable 1 Classification results
Classifier* Cost TP rate FP Ra
CSC Naïve Bayes 38 54.5 20.1
CSC Random Forest 65000 60.2 19.0
*CSC denotes CostSensitiveClassifier, # Balanced Classification Rate.for classification tasks. Owing to the large size of the
dataset Weka was started with an increased heap space
of 4 GB to handle out-of-memory exception. Initially
standard classifiers were used to generate the models,
however, due to the low true positives rate, cost sensitiv-
ity was introduced and the cost was incremented so as
to stay around the upper limit of false positives (i.e.
20%). Final misclassification cost of false negatives used
for both the classifiers is given in Table 1. The Naive
Bayes required a lower misclassification cost and was
very quick in building the model. A number of models
were trained with different misclassification cost set-
tings. The best models from both classifiers were
selected based on their performance as evaluated by dif-
ferent statistical measures (Table 1).
Evaluation of models
Initial evaluation was performed using sensitivity and
specificity plots (Figure 1) for best models of both the
classifiers. An experiment generating high sensitivity and
specificity is considered to have low error rates. As can
be visualized from the graph, though Random Forest is
more sensitive as compared to Naïve Bayes, both the
classifiers are equally specific in their predictions. Trad-
itionally, the most simple and commonly used assess-
ment metric for describing the overall effectiveness of a
classifier was by its accuracy. In the present study both
the classifiers produced an impressive accuracy of nearly
80%, but this measure has its own short-comings when
applied to highly imbalanced datasets where positive
examples are under-represented as compared to negative
examples as in our dataset. In lieu of this, other per-
formance measures are now being widely adopted so as
to provide a more detailed and comprehensive evalu-
ation of the datasets having a class imbalance problem.
BCR is a popularly used assessment metrics for imbal-
anced datasets. Since BCR provides an average of sensitiv-
ity and specificity, it gives a more precise picture of
classifier effectiveness. Balanced Accuracy of the classifiers
also turned out to be as good as was accuracy alone
(Figure 2). BCR value of Random Forest and Naïve Bayes
was 70% and 66% respectively. Relative classifier perform-
ance can be easily compared by ROC curve analysis. It is
extremely efficient measure as it provides visualization of
relative trade-offs between true positives and false posi-
tives. The Area under the curve (AUC) obtained from
ROC plot of the two classifiers depicted in Figure 3, sug-
gested that Random Forest performed better producing ate ROC area Accuracy (%) BCR# (%)
72.8 79.85 66
77.3 81.19 70
Figure 3 ROC plot depicting significant AUC curve values for
random forest and naïve bayes.
Figure 1 Plot of sensitivity and specificity.
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completely random guess by the classifier would have
resulted in points lying along the diagonal dividing the
ROC space.
Evaluation of enriched substructures
Although molecular descriptor based methods are com-
putationally simple and effective in practice but they
share several shortcomings most important being the in-
ability to identify local similarity between structures.
This is important for chemists in understanding and
synthesizing molecules based on active scaffolds. The ac-
tive dataset containing 883 compounds was clustered
using the LibMCS algorithm which generated a total of
1151 hierarchical scaffolds/substructures spanning up to 6
levels. Only top level clusters were selected for further
analysis. The number of clusters at level 6 was 182. Out of
the 182 clusters, 71 were singletons which were removed
from further analysis whereas remaining selected 111 clus-
ters had compounds count ranging from 2–144. The
number of occurrence of each of the 111 substructures in
the actives and the inactives dataset was determined. We
considered only substructures with a frequency ofFigure 2 Comparison of accuracy and balanced classification
rate.occurrence of > 1% in the active dataset which accounted
for 41 scaffolds. The enrichment and its significance, was
analyzed by chi-square test (Table 2). Analysis revealed 14
significantly enriched scaffolds in the active dataset which
had p-value less than 0.01 and an enrichment factor > 2.
We also performed an alignment of the 14 enriched
scaffolds with top 20 compounds of the active data-
set (Figure 4). The Tanimoto similarity and overlap
between query scaffold and target active dataset were
used as a means to rank matches.
DrugBank and Protein Data Bank (PDB) database
screening
We used the predictive models to screen approved
drugs from DrugBank database [23]. Out of the 1410
approved drugs NB model predicted 205 drugs and RF
model predicted 74 drugs to be active against miR-21
(Additional file 2). A consensus from both the models
resulted in 43 drugs. A clustering analysis of the 43
drugs (Additional file 3) revealed the presence of mostly
heterocyclic compounds comprising benzenes, quino-
lines, furans, pyridines and their derivatives. The 14 sig-
nificantly enriched scaffolds were searched in the Protein
Data Bank [24] to identify any similarity with known
RNA binding ligands. One positive hit was obtained
(Additional file 4) for Scaffold 3 which matched with the
ligand ‘triazole-acridine’ (PDB-id: R14) which is known to
bind to telomeric RNA-quadruplex (PDB-id: 3MIJ) [25].
Virtual screening of experimentally identified novel
miRNA inhibitors
We have also used the predicted models to screen a set
of novel molecules identified as miRNA inhibitors
derived from different literature sources [14-16,26,27].
Out of the 37 molecules reported as actives in these
Table 2 Significantly enriched scaffolds in the active dataset
Scaffold_No. Scaffold_structure Actives Inactives Chi-square p-value Enrichment factor
Scaffold 1 19 86 1144.377 0.00 75.49
Scaffold 2 14 97 579.406 0.00 49.32
Scaffold 3 15 623 93.197 4.73E-22 8.22
Scaffold 4 13 628 66.565 3.38E-16 7.07
Scaffold 5 14 692 69.573 7.36E-17 6.91
Scaffold 6 14 878 50.204 1.39E-12 5.44
Scaffold 7 28 2186 72.564 1.62E-17 4.37
Scaffold 8 14 1140 33.804 6.09E-09 4.19
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Table 2 Significantly enriched scaffolds in the active dataset (Continued)
Scaffold 9 12 1090 24.158 8.87E-07 3.76
Scaffold 10 21 1999 39.091 4.04E-10 3.58
Scaffold 11 14 1356 25.217 5.12E-07 3.52
Scaffold 12 10 1086 14.563 1.35E-04 3.14
Scaffold 13 11 1405 11.505 6.94E-04 2.67
Scaffold 14 14 1852 13.566 2.30E-04 2.58
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predicted 11 molecules as actives (Additional file 5).
Consensus predictions made by both the models sug-
gested 11 molecules to have probable activity against
miR-21.
Conclusion
Understanding small molecules that bind to RNA could
have implications both in modulating RNA levels for re-
search as well as therapeutic applications. In this study, we
have been successful in creating predictive computational
models for small molecules with potential to bind andinhibit microRNA action using machine learning algo-
rithms and chemical descriptors. We show the method-
ology is highly accurate with low false positivity. This
methodology could be potentially used for computational
screen of datasets before performing high-throughput
screen as well as picking potential hits from large chemical
structure datasets. In addition we have evaluated the max-
imally enriched substructures in the active dataset of small
molecules with activity against mir-21. Apart from being
involved in the pathogenesis of neoplasia, mir-21 is also
known to be involved in the pathogenesis of Mycobacter-
ium leprae [28] and is suggested to be involved in the
Figure 4 Molecular overlay. Alignment of 14 enriched scaffolds (dark green) with top 20 compounds of active dataset. Ranking was obtained
from their Tanimoto similarity and overlap with the reference scaffold.
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gens including Mycobacterium tuberculosis [29]. Recent
evidence has also suggested that microRNA apart from
others to be differentially expressed in individuals with la-
tent tuberculosis [30].This would also serve as the starting
point to understand and design molecule libraries both
virtual as well as experimental for specific activities for
both research and therapeutic applications. To the best of
our knowledge this is the first comprehensive analysis of




The dataset [AID: 2289] consisting of modulators of
human microRNA, miR-21 was downloaded from Pub-
Chem [31]. The high-throughput screen consisted of a
total of 3,33,521 tested compounds. Compounds were
characterized based on a compound ranking system called
‘PubChem Activity Score’. Compounds having an activityscore between 40 and 100 were considered as active (3282),
all compounds with a score of 0 were inactives (3,01,747)
and the ones having a score between 1 and 39 were labeled
as inconclusive (28,713). The active and inactive sets were
downloaded in Structure Data Format (SDF).
The bioactivity of compounds in the high throughput
screen of PubChem AID2289 has been measured in a
cell-based Firefly Luciferase (FLuc) reporter gene assay.
However, it has earlier been reported [32,33] that com-
pounds that resemble substrates of FLuc can potentially
function as competitive inhibitors of the enzyme thereby
resulting in counterintuitive phenomenon of signal acti-
vation. The apparent increase in luminescence could
thus be mistakenly interpreted as an activity. Therefore,
we also used the counter-screen of mir-21 project (AID:
588342) that uses a ~350 k library of MLSMR compounds
to filter out true positives from potentially false positives.
The overlapping revealed that 2399 compounds in the ac-
tive set of AID2289 are inhibitors of FLuc rather than our
target miR-21. All overlaps were filtered out and only 883
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experiments (Additional file 6).
Dataset preparation
The chemical structures downloaded from PubChem
were imported and 2D descriptors were generated using
PowerMV [34]. The large dataset was split into smaller
files using SplitSDFiles from Mayachem tools [35]. A
total of 179 descriptors were calculated which includes
147 pharmacophore fingerprints, 24 weighted burden
number and 8 property descriptors (Additional file 1).
For the bit string descriptors, each bit was set to ‘1’
when a certain feature was presented and ‘0’ when it
was not. The attributes having bit string descriptor
values of only one value throughout the dataset (all
0’s or all 1’s) were filtered. The dataset was split into
20% test set and the 80% training-cum-validation set
to build the model.
Cost sensitive classification
One of the caveats with the virtual screening of bioassay
data is the imbalance between active and inactive com-
pounds [36]. A dataset is considered imbalanced when
one class is represented by large number of entities as
compared to other. To overcome this problem cost-
sensitive classification has been used previously [37]. In
cost sensitive learning, misclassification of the marginal
class is assigned a high cost which the algorithm then
attempts to lessen. We used Weka (Waikato Environment
for Knowledge Analysis), a popular suite of machine learn-
ing software, to perform modeling tasks [38]. In Weka,
cost sensitivity is introduced by means of a confusion
matrix. In the present binary classification scheme a 2x2
matrix was deployed to predict the class with the mini-
mum expected misclassification cost setting. A 2x2 confu-
sion matrix consists of four sections: True positives (TP)
for active compounds correctly classified as active, false
positives (FP) for inactive compounds incorrectly classified
as active, true negatives (TN) for inactive compounds cor-
rectly classified as inactive and false negatives (FN) for ac-
tive compounds incorrectly classified as inactive. As false
negatives are deemed to be more important in any experi-
ment, misclassification cost was set for false negatives and
was incremented serially so as to optimize the predictions.
The maximum false positive rate is constrained to
approximately 20%. The optimal misclassification cost
setting for each classifier in the Weka cost matrix
depends on the base classifier used. The model was
first build with training dataset and 5-fold cross valid-
ation was used during training of data. Cross validation
is a technique in which data is partitioned into subsets,
performing the analysis on one subset (called the train-
ing set), and validating the analysis on the other subset
(called the validation set or testing set). The base classi-
fiers used were Naive Bayes and Random forest. Forboth Naive Bayes and Random forest, cost sensitivity
was employed.
Classification methods
Machine learning is a field of artificial intelligence and is
based on prediction of a set of outcomes, based on
known properties learned from a dataset of known out-
comes, otherwise termed as the training data. In our ex-
periment the following algorithms were used which can
be formulated in terms of machine learning methods.
Naïve Bayes is one of the simplest probabilistic classi-
fier. The technique is based on Bayes theorem in statistics.
A Bayesian classifier considers each structural feature or
descriptor independent of the other descriptors, and the
probability of activity is considered to be proportional to
the ratio of actives to inactives that share the descriptor
value. The final probability that a compound is active is a
product of all descriptor based probabilities [39].
Random Forest was first described by Leo Breiman [40].
It is an ensemble classifier methodology based on decision
trees. The algorithm tries to find as good a distinction as
possible between active compounds and others, on the
basis of a set of molecular descriptors. It identifies features
shared by different subsets of active compounds and ac-
cordingly filters out compounds within the target data set
in which these combinations are lacking. It is the most ac-
curate classifiers available.
Model evaluation
We used various statistical measures such as Accuracy,
Sensitivity, Specificity, Balanced Classification Rate (BCR)
and Receiver Operating Characteristic (ROC) to evaluate
the models. Sensitivity, Specificity and Accuracy are
expressed in terms of true positive (TP), false negative
(FN), true negative (TN), false positive (FP) rates. A True
Positive Rate (TPR) is the proportion of actual positives
which are correctly predicted as actives (TP/TP+FN).
False Positive Rate (FPR) is ratio of predicted false actives
to actual number of inactives (FP/FP+TN). Accuracy
indicates overall effectiveness of the classifier. It can be
calculated as (TP+TN/TP+TN+FP+FN). Sensitivity
refers to proportion of actual positives which are predicted
positives (TP/TP+FN). Specificity refers to proportion of
actual negatives which are predicted negatives (TN/TN+
FP). Balanced Classification Rate (BCR) is the average of
sensitivity and specificity which may be defined as a meas-
ure to test classifiers ability to avoid false classification.
Maximum common substructure search
A maximum common substructure (MCS) based ap-
proach was used to identify potentially enriched bioactive
molecules. We used the hierarchical clustering algorithm
‘LibMCS’, available from ChemAxon [41] to recognize the
substructure common to a pair of molecules. This MCS
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where one molecule belongs to one cluster only. The size
of the MCS is determined as a function of the numbers of
the constituent atoms which was empirically set to a
threshold of ”10 atoms” in this study owing to the com-
plexity of the structures involved and computation
required to generate the clusters.
The molecular scaffolds generated as a result of
clustering were thus used as SMILES query to search
for substructures in both active and inactive target
datasets. This was accomplished using the ‘jcsearch’
algorithm available from ChemAxon [42]. The sub-
structures were later evaluated for enrichment using
chi-square test. The p-values were used to evaluate
the significance of enrichment. We used substruc-
tures which have at least > 1% matches among the ac-
tive dataset entries. We also calculated enrichment
factor and used an empirical threshold of 2 to prioritize
molecules for further analysis. A molecular alignment of
the selected scaffolds with molecules of active dataset
was performed using the vROCS (release 3.1.2) [43] and
visualized in VIDA (4.1.1) [44] available from OpenEye
Scientific Software, Inc. [45].
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